Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Konigshoff (Denver, United States of America). Disrupted alveolar repair in COPD: lessons from patient studies and models systems. International Congress 2018 – Pathophysiology of the human lung alveolus

Member's Comments

No comment yet.

Related content which might interest you: Proteostasis and the alveolar epithelium in health and disease: lessons from the surfactant system Source: Research Seminar 2014 - Protein quality control in lung disease Year: 2014 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Inflammatory cells and airway remodelling in COPD: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Additive layer manufacturing of physiologically realistic patient specific airway models for study of flow modifications in asthma and COPD Source: Annual Congress 2013 –Functional imaging Year: 2013 Investigation and assessment of airway and lung inflammation: we now have the tools, what are the questions? Source: Guideline 1998 Year: 1998 Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment Source: Eur Respir J, 52 (4) 1801718; 10.1183/13993003.01718-2018 Year: 2018 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Excessive dynamic airway collapse in patients with COPD: preliminary results Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution Year: 2009 Late Breaking Abstract - Generating iPSC derived alveolar macrophages as a novel model for respiratory research Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Late Breaking Abstract - Nano-mechanical properties of bronchial wall biopsies as a potential remodeling marker in obstructive lung disease - preliminary findings. Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models Source: Eur Respir Rev 2014; 23:231-238 Year: 2014 Effect of spirometry on COPD management in primary care: where are the studies that we really need? Source: Eur Respir J 2007; 29: 820 Year: 2007 How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Source: Eur Respir J 2006; 27: 248-249 Year: 2006 Alveolar NO and alveolar inflammation: biological links and clinical implications Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease Year: 2010 Targeted pulmonary rehabilitation and nutritional support in patients with COPD: do phenotypic differences matter?  Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies Year: 2017